Correlation between p53 immunostaining patterns and gene sequence mutations in breast carcinoma

Diagnostic Molecular Pathology

Volumn 5, Issue 3, 1996, Pages 187-193

  Visscher, Daniel W ^a,b   Sarkar, Fazlul H ^a   Shimoyama, Rie K ^a   Crissman, John D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Breast carcinoma; p53 immunohistochemistry; SSCP analysis

Indexed keywords

PROTEIN P53;

ARTICLE; BREAST CARCINOMA; CANCER GENETICS; CANCER RECURRENCE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; STATISTICAL ANALYSIS;

ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DNA, NEOPLASM; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; INDICATORS AND REAGENTS; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; STAINING AND LABELING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029787441     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199609000-00007     Document Type: Article

References (16)

1. Allred DC, Clark GM, Elledge R, et al. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 1993;85:200-6.
2. Baas IO, Mulder J-WR, Offerhaus GJA, Vogelstein B, Hamilton SR. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994;172:5-12.
3. Battifora H. pS3 immunohistochemistry: a word of caution. Hum Pathol 1994;25:435-7.
4. Eyfjörd JE, Thorlacius S, Steinarsdottir M, Valgardsdottir R, Ogmundsdottir HM, Anamthawat-Jonsson K. p53 abnormalities and genomic instability in primary human breast carcinomas. Cancer Res 1995;55:646-51.
5. Hall PA, Lane DP. p53 in tumour pathology: can we trust immunohistochemistry? - Revisited! J Pathol 1994;172:1-4.
6. Jacquemier J, Molès JP, Penault-Llorca F, et al. p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results. Br J Cancer 1994;69:846-52.
7. Lambkin HA, Mothersill CM, Kelehan P. Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection. J Pathol 1994;172:13-8.
8. Nakamori S, Yashima K, Murakami Y, et al. Association of p53 gene mutations with short survival in pancreatic adenocarcinoma. Jpn J Cancer Res 1995;86:174-181.
9. Lane DP. On the expression of the p53 protein in human cancer. Mol Biol Rep 1994;19:23-9.
10. Sommer SS, Cunningham J, McGovern RM, Saitoh S, Schroseder JJ, Wold LE, Kovach JS. Pattern of p53 gene mutations in breast cancers of women in the midwestern United States. J Natl Cancer Inst 1992;84:246-52.
11. Suzuki Y, Sekiya T, Hayashi K. Allele-specific polymerase chain reaction: a method for amplification and sequence determination of a single component among a mixture of sequence variants. Anal Biochem 1991;192:82-4.
12. Thor AD, Moore DH, Edgerton SM, et al. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 1992;84: 845-55.
13. Tsuda H, Hirohashi S. Association among p53 gene mutation, nuclear accumulation of the p53 protein and aggressive phenotypes in breast cancer. Int J Cancer 1994;57:498-503.
14. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992;70:523-6.
15. Wynford-Thomas D. p53 in tumour pathology: can we trust immunocytochemistry? J Pathol 1992;166:329-30.
16. Xu L, Chen Y-T, Huvos AG, Zlotolow IM, Rettig WJ, Old LJ, Garin-Chesa P. Overexpression of p53 protein in squamous cell carcinomas of head and neck without apparent gene mutations. Diagn Mol Pathol 1994;3:83-92.